147 related articles for article (PubMed ID: 31690830)
1. Post-neoadjuvant cellular dissociation grading based on tumour budding and cell nest size is associated with therapy response and survival in oesophageal squamous cell carcinoma.
Jesinghaus M; Boxberg M; Wilhelm D; Münch S; Dapper H; Quante M; Schlag C; Lange S; Budczies J; Konukiewitz B; Mollenhauer M; Schlitter AM; Becker KF; Feith M; Friess H; Steiger K; Combs SE; Weichert W
Br J Cancer; 2019 Dec; 121(12):1050-1057. PubMed ID: 31690830
[TBL] [Abstract][Full Text] [Related]
2. Cellular dissociation grading on biopsies of pulmonary squamous cell carcinoma provides prognostic information across all stages and is congruent with resection specimen grading.
Jesinghaus M; Boxberg M; Schmitt M; Kriegsmann M; Harms A; Lang C; Muley T; Winter H; Kriegsmann K; Warth A; Stenzinger A; Denkert C; Hoffmann H; Safi S; Weichert W
J Pathol Clin Res; 2022 Nov; 8(6):567-578. PubMed ID: 36111649
[TBL] [Abstract][Full Text] [Related]
3. Cellular Dissociation Grading Based on the Parameters Tumor Budding and Cell Nest Size in Pretherapeutic Biopsy Specimens Allows for Prognostic Patient Stratification in Esophageal Squamous Cell Carcinoma Independent From Clinical Staging.
Jesinghaus M; Brühl F; Steiger K; Klare P; Reiser M; Scheiter A; Konukiewitz B; Kuhn P; Münch S; Quante M; Schmid RM; Wilhelm D; Feith M; Friess H; Combs SE; Saur D; Boxberg M; Weichert W
Am J Surg Pathol; 2019 May; 43(5):618-627. PubMed ID: 30807302
[TBL] [Abstract][Full Text] [Related]
4. A Novel Grading System Based on Tumor Budding and Cell Nest Size Is a Strong Predictor of Patient Outcome in Esophageal Squamous Cell Carcinoma.
Jesinghaus M; Boxberg M; Konukiewitz B; Slotta-Huspenina J; Schlitter AM; Steiger K; Specht K; Wieczorek K; Warth A; Schmidt T; Hartmann A; Demir IE; Feith M; Ott K; Weichert W
Am J Surg Pathol; 2017 Aug; 41(8):1112-1120. PubMed ID: 28505009
[TBL] [Abstract][Full Text] [Related]
5. Introducing a novel highly prognostic grading scheme based on tumour budding and cell nest size for squamous cell carcinoma of the uterine cervix.
Jesinghaus M; Strehl J; Boxberg M; Brühl F; Wenzel A; Konukiewitz B; Schlitter AM; Steiger K; Warth A; Schnelzer A; Kiechle M; Beckmann MW; Noske A; Hartmann A; Mehlhorn G; Koch MC; Weichert W
J Pathol Clin Res; 2018 Apr; 4(2):93-102. PubMed ID: 29665323
[TBL] [Abstract][Full Text] [Related]
6. Combined assessment of tumour cell nest size and desmoplastic reaction as an excellent prognostic predictor in oesophageal squamous cell carcinoma.
Li ZW; He L; Zheng Z; Zhang Q; Xu YT; Chen JY; Shi J; Huang WB; Fan XS
Histopathology; 2022 Jun; 80(7):1112-1120. PubMed ID: 35353393
[TBL] [Abstract][Full Text] [Related]
7. Pre-operative cellular dissociation grading in biopsies is highly predictive of post-operative tumour stage and patient outcome in head and neck squamous cell carcinoma.
Jesinghaus M; Steiger K; Stögbauer F; Haller B; Kolk A; Straßen U; Pickhard A; Wirth M; Silva M; Budczies J; Becker von Rose A; Konukiewitz B; Kuhn P; Klinghammer K; Dapper H; Münch S; Combs SE; Weichert W; Boxberg M
Br J Cancer; 2020 Mar; 122(6):835-846. PubMed ID: 31937923
[TBL] [Abstract][Full Text] [Related]
8. Tumour budding activity and cell nest size determine patient outcome in oral squamous cell carcinoma: proposal for an adjusted grading system.
Boxberg M; Jesinghaus M; Dorfner C; Mogler C; Drecoll E; Warth A; Steiger K; Bollwein C; Meyer P; Wolff KD; Kolk A; Weichert W
Histopathology; 2017 Jun; 70(7):1125-1137. PubMed ID: 28122134
[TBL] [Abstract][Full Text] [Related]
9. Residual Cancer Volume Predicts Clinical Outcome in Patients With Esophageal Squamous Cell Carcinoma After Neoadjuvant Chemotherapy.
Nakao R; Konishi E; Fujiwara H; Otsuji E; Yokota I; Urata Y; Yanagisawa A
Int J Surg Pathol; 2019 Oct; 27(7):713-721. PubMed ID: 31203677
[No Abstract] [Full Text] [Related]
10. Evaluation of the Cellular Dissociation Grading, Based on Tumor Budding and Cell Nest Size, in Squamous Cell Carcinoma of the Penis.
Derani H; Becker AS; Hakenberg O; Erbersdobler A
Cancers (Basel); 2022 Oct; 14(19):. PubMed ID: 36230870
[TBL] [Abstract][Full Text] [Related]
11. Analysis of SPARC and TUBB3 as predictors for prognosis in esophageal squamous cell carcinoma receiving nab-paclitaxel plus cisplatin neoadjuvant chemotherapy: a prospective study.
Gong L; Mao W; Chen Q; Jiang Y; Fan Y
Cancer Chemother Pharmacol; 2019 Apr; 83(4):639-647. PubMed ID: 30643929
[TBL] [Abstract][Full Text] [Related]
12. Neoadjuvant chemoradiation for patients with advanced oesophageal cancer - which response grading system best impacts prognostic discrimination?
Puetz K; Bollschweiler E; Semrau R; Mönig SP; Hölscher AH; Drebber U
Histopathology; 2019 Apr; 74(5):731-743. PubMed ID: 30636069
[TBL] [Abstract][Full Text] [Related]
13. A Novel Prognostic Stratified System Based on Tumor Budding and the Cell Nest Size in Ureter Urothelial Carcinoma.
Li J; Li X; Yang J
Appl Bionics Biomech; 2022; 2022():6988237. PubMed ID: 35572056
[TBL] [Abstract][Full Text] [Related]
14. Intratumoral
Yamamura K; Izumi D; Kandimalla R; Sonohara F; Baba Y; Yoshida N; Kodera Y; Baba H; Goel A
Clin Cancer Res; 2019 Oct; 25(20):6170-6179. PubMed ID: 31358543
[TBL] [Abstract][Full Text] [Related]
15. GR, Sgk1, and NDRG1 in esophageal squamous cell carcinoma: their correlation with therapeutic outcome of neoadjuvant chemotherapy.
Ueki S; Fujishima F; Kumagai T; Ishida H; Okamoto H; Takaya K; Sato C; Taniyma Y; Kamei T; Sasano H
BMC Cancer; 2020 Feb; 20(1):161. PubMed ID: 32106831
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of the 7th edition of the TNM classification in patients with resected esophageal squamous cell carcinoma.
Wang J; Wu N; Zheng QF; Yan S; Lv C; Li SL; Yang Y
World J Gastroenterol; 2014 Dec; 20(48):18397-403. PubMed ID: 25561808
[TBL] [Abstract][Full Text] [Related]
17. Histomorphologic tumor regression and lymph node metastases determine prognosis following neoadjuvant radiochemotherapy for esophageal cancer: implications for response classification.
Schneider PM; Baldus SE; Metzger R; Kocher M; Bongartz R; Bollschweiler E; Schaefer H; Thiele J; Dienes HP; Mueller RP; Hoelscher AH
Ann Surg; 2005 Nov; 242(5):684-92. PubMed ID: 16244542
[TBL] [Abstract][Full Text] [Related]
18. Tumor/normal esophagus ratio in (18)F-fluorodeoxyglucose positron emission tomography/computed tomography for response and prognosis stratification after neoadjuvant chemotherapy for esophageal squamous cell carcinoma.
Izumi D; Yoshida N; Watanabe M; Shiraishi S; Ishimoto T; Kosumi K; Tokunaga R; Taki K; Higashi T; Harada K; Miyata T; Ida S; Imamura Y; Iwagami S; Baba Y; Sakamoto Y; Miyamoto Y; Yamashita Y; Baba H
J Gastroenterol; 2016 Aug; 51(8):788-95. PubMed ID: 26671045
[TBL] [Abstract][Full Text] [Related]
19. Neoadjuvant Chemotherapy Increases PD-L1 Expression and CD8
Fukuoka E; Yamashita K; Tanaka T; Sawada R; Sugita Y; Arimoto A; Fujita M; Takiguchi G; Matsuda T; Oshikiri T; Nakamura T; Suzuki S; Kakeji Y
Anticancer Res; 2019 Aug; 39(8):4539-4548. PubMed ID: 31366557
[TBL] [Abstract][Full Text] [Related]
20. Prognostic significance of tumor regression in lymph nodes after neoadjuvant therapy for rectal carcinoma.
Fernández-Aceñero MJ; Granja M; Sastre J; García-Paredes B; Estrada L
Virchows Arch; 2016 Apr; 468(4):425-30. PubMed ID: 26754675
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
